{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:04:09Z","timestamp":1779300249011,"version":"3.51.4"},"reference-count":65,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1507\/endocrj.kr-105","type":"journal-article","created":{"date-parts":[[2007,9,13]],"date-time":"2007-09-13T05:48:56Z","timestamp":1189662536000},"page":"487-495","source":"Crossref","is-referenced-by-count":54,"title":["Prevalence of Primary Aldosteronism: Should We Screen for Primary Aldosteronism before Treating Hypertensive Patients with Medication?"],"prefix":"10.1507","volume":"54","author":[{"given":"Tetsuo","family":"NISHIKAWA","sequence":"first","affiliation":[{"name":"Division of Endocrinology & Metabolism, Department of Medicine, Yokohama Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"SAITO","sequence":"additional","affiliation":[{"name":"Division of Endocrinology & Metabolism, Department of Medicine, Yokohama Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"OMURA","sequence":"additional","affiliation":[{"name":"Department of Medical Examination, Yokohama Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Padfield PL (2003) Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice. Clin Endocrinol 59: 422-426.","DOI":"10.1046\/j.1365-2265.2003.01817.x"},{"key":"2","unstructured":"2. Conn JW (1955) Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 6-17."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Conn JW, Cohen EL, Rovner DR (1964) Suppression of plasma renin activity in primary aldosteronism. J Am Med Assoc 190: 213-221.","DOI":"10.1001\/jama.1964.03070160037008"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.8.2854"},{"key":"5","unstructured":"5. Conn JW (1968) The evolution of primary aldosteronism: 1954-1967. Harvey Lect 62: 257-291."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nadar S, Lip GYH, Beevers DG (2003) Primary hyperaldosteronism. Ann Clin Biochem 40: 439-452.","DOI":"10.1258\/000456303322326362"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Connell JM (2002) Is there an epidemic of primary hyperaldosteronism. J Hum Hypertens 16: 151-152.","DOI":"10.1038\/sj.jhh.1001319"},{"issue":"4","key":"8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0305-1870","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM (2000) High prevalence of primary hyperaldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 14: 311-315.","DOI":"10.1038\/sj.jhh.1001013"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(64)90249-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Terzolo M, Ali A, Osella G, Mazza E (1997) Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 132: 914-919.","DOI":"10.1001\/archsurg.1997.01430320116020"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ferriss JB, Beevers DG, Brown JJ, Davies DL, Fraser R, Lever AF, Mason P, Neville AM, Robertson JI (1978) Clinical, biochemical and pathological features of low-renin (`primary') hyperaldosteronism. Am Heart J 95: 375-388.","DOI":"10.1016\/0002-8703(78)90370-8"},{"key":"13","unstructured":"13. Salomon MI, Tchertkoff V (1968) Incidence and role of adrenocortical tumors in hypertension. Geriatrics 23: 184."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Russell RP, Masi AT, Ritcher ED (1972) Adrenal cortical adenomas and hypertension. Medicine 51: 211-225.","DOI":"10.1097\/00005792-197205000-00007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Anderson GH, Blakerman N, Streeten DHP (1994) The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12: 609-615.","DOI":"10.1097\/00004872-199405000-00015"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.193"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nishikawa T, Omura M (2000) Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother 54 (Suppl 1): 83-85.","DOI":"10.1016\/S0753-3322(00)80019-0"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.205.7.497"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715010-00006"},{"key":"20","unstructured":"20. Gordon R (1999) Incidence and workup of primary aldosteronism &mdash; Greenslopes Hospital Series. Primary aldosteronism and adrenal incidentaloma &mdash; into a new millennium. Couran Cove Resort, South Stradbroke Island Queensland, Australia, 13 September, p. 13 (Abstract)."},{"key":"21","unstructured":"21. Young WF Jr (1999) Incidence and workup of primary aldosteronism &mdash; Mayo Clinic. Primary aldosteronism and adrenal incidentaloma &mdash; into a new millennium. Couran Cove Resort, South Stradbroke Island Queensland, Australia, 13 September, p. 12 (Abstract)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM (1999) Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353: 40.","DOI":"10.1016\/S0140-6736(05)74868-6"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.5.1863"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02969-2"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001554"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocinol Metab 89: 1045-1050.","DOI":"10.1210\/jc.2003-031337"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Williams JS, Williams GH, Raji A, Jeunemaitre X, Brown NJ, Hopkins PN, Conlin PR (2006) Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalemia. J Hum Hypertens 20: 129-136.","DOI":"10.1038\/sj.jhh.1001948"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200405000-00001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC (1997) Remodeling of the left ventricular in primary aldosteronism due to Conn's adenoma. Circulation 95: 1471-1478.","DOI":"10.1161\/01.CIR.95.6.1471"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)03199-0"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.303"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.781"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kono T, Ikeda F, Oseko F, Imura H, Tanimura H (1981) Normotensive primary aldosteronism: report of a case. J Clin Endocrinol Metab 52: 1009-1013.","DOI":"10.1210\/jcem-52-5-1009"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Brown MA, Cramp HA, Zammit VC, Whitworth JA (1996) Primary aldosteronism: a missed diagnosis in \"essential hypertensives\"? Aust NZ J Med 26: 533-538.","DOI":"10.1111\/j.1445-5994.1996.tb00600.x"},{"key":"35","unstructured":"35. Lim PO, Brennan G, Shiels P, et al. (1998) Unexpectedly high prevalence of primary aldosteronism in a hypertensive population in Dundee, Edinburgh (Abstract). British Endocrine Society. J Endocrinol 156 (Suppl):S1-43."},{"key":"36","unstructured":"36. Kumar A, Lall SB, Ammini A, Peshin SS, Karmarkar MG, Talwar KK, Sath SD (1994) Screening of a population of young hypertensives for primary hyperaldosteronism (correspondence). J Hum Hypertens 8: 731-732."},{"key":"37","unstructured":"37. Rayner BL, Opie LH, Davidson JS (2000) The aldosterone\/renin ratio as a screening test for primary hyperaldosteronism. S Afr Med J 90: 394-400."},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh112"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch Intern Med 141: 1589-1593.","DOI":"10.1001\/archinte.1981.00340130033011"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC (2001) Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 37: 699-705.","DOI":"10.1016\/S0272-6386(01)80117-7"},{"key":"41","unstructured":"41. Kaplan NM (1998) Primary hypertension: pathogenesis. Clinical Hypertension, 7th edn. Baltimore: Williams and Wilkins, 60-63."},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04223-9"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K (2003) Variability in the renin-aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab 88: 2489-2494.","DOI":"10.1210\/jc.2002-021476"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Montori VM, Young WF Jr (2002) Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin N Am 31: 619-632.","DOI":"10.1016\/S0889-8529(02)00013-0"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Van Buchem FSP, Doorenbos H, Elings HS (1956) Primary aldosteronism due to adrenocortical hyperplasia. Lancet 271: 335-337.","DOI":"10.1016\/S0140-6736(56)92194-8"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(65)90122-1"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Banks WA, Kastin AJ, Biglieri EG, Ruiz AE (1984) Primary adrenal hyperplasia: A new subset of primary hyperaldosteronism. J Clin Endocrinol Metab 58: 783-785.","DOI":"10.1210\/jcem-58-5-783"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(55)90163-7"},{"key":"49","unstructured":"49. Sutherland DJA, Ruse JL, Laidlaw JC (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Canad Med Ass J 95: 1109-1119."},{"issue":"5","key":"50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","volume":"18","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0305-1870","issn-type":"print"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2002.30498"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, Yune HY, Wellman H, Donohue JP (1979) Primary aldosteronism. Ann Intern Med 90: 386-395.","DOI":"10.7326\/0003-4819-90-3-386"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Ganguly A (1998) Primary aldosteronism. New Engl J Med 339: 1828-1834.","DOI":"10.1056\/NEJM199812173392507"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)06102-9"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200103000-00001"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Blumenfeld JD, Sealey JE, Schlussel Y, Vaughan ED Jr, Sos TA, Atlas SA, Muller FB, Acevedo R, Ulick S, Laragh JH (1994) Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 121: 877-885.","DOI":"10.7326\/0003-4819-121-11-199412010-00010"},{"key":"57","unstructured":"57. Weinberger MH, Grim CE, Hollifield JW (1979) Primary hyperaldosteronism. Diagnosis, localization and treatment. Ann Intern Med 67: 403-413."},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.883"},{"key":"59","unstructured":"59. Nishikawa T, Saito J, Omura M (2006) Prospective study on prevalence of aldosterone-producing adenoma and idiopathic hyperaldosteronism among patients with primary aldosteronism. J Tokyo Wom Med Univ 76: 267-269."},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.12.4526"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA (2004) Role of adrenal venous sampling in primary aldosteronism. Surgery 136: 1227-1235.","DOI":"10.1016\/j.surg.2004.06.051"},{"key":"62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.3.1083"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200311000-00025"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Young WF Jr (2003) Minireview: Primary aldosteronism &mdash; changing concepts in diagnosis and treatment. Endocrinology 144: 2208-2213.","DOI":"10.1210\/en.2003-0279"},{"key":"65","unstructured":"65. Kaplan NM (2006) Primary aldosteronism, in Kaplan's Clinical Hypertension, Ninth Edition, Lippincott Williams &#38; Wilkins, p.410-433."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/54\/4\/54_4_487\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:56:37Z","timestamp":1618296997000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/54\/4\/54_4_487\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.kr-105","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}